Clinical Trial Update: A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

View source ↗

Summary

A completed clinical trial evaluated the Dermacorder device for detecting malignant skin lesions in patients with basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Dermacorder

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Basal Cell Carcinoma | Status: COMPLETED